Home Osprey Medical

Osprey Medical

In operation
IPO
Developer of Medical Devices for Contrast-Induced Nephropathy

Basic Information

Osprey Medical is dedicated to the research and development of medical devices for contrast-induced nephropathy, the CINCOR™ system, designed for the prevention of contrast-induced nephropathy (protein). The appropriate development and commercialization of the CINCOR system. The CINCOR system is derived from technology developed by the Baker Heart and Diabetes Institute in Melbourne, Australia.
Osprey Medical Inc.
Minnesota,United States of America
more than 500 people
January 01, 2005
Customerservice@ospreymed.com